Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2021 | Impact of the COVID-19 pandemic on primary endocrine treatment

Carol Benn • 14 Mar 2021
BCC 2021
Breast Cancer

Carol Benn, MBBCh, FCS, Breast Care Center of Excellence, Milpark Hospital, Johannesburg, South Africa, discusses the impact of the SARS Cov-2 pandemic on primary endocrine treatment, and outlines ongoing trends in this field. This interview took place during the 17th St. Gallen International Breast Cancer Conference.

More from Carol Benn

Access to therapies in South Africa for patients with breast cancer
3:40
Access to therapies in South Africa for patients with breast cancer
Carol Benn • 14 Mar 2021
Highlights from BCC 2021: loco-regional management of the axilla
1:37
Highlights from BCC 2021: loco-regional management of the axilla
Carol Benn • 14 Apr 2021
Global significance of virtual meetings
0:48
Global significance of virtual meetings
Carol Benn • 14 Mar 2021

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals